Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter


TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential




Share Price Information for Valirx (VAL)


Share Price: 0.235Bid: 0.22Ask: 0.25Change: 0.02 (+9.30%)Riser - Valirx
Spread: 0.03Spread as %: 13.64%Open: 0.215High: 0.24Low: 0.215Yesterday’s Close: 0.215

Valirx Plc Ord 0.1P

Valirx is listed in the FTSE AIM All-Share
Valirx is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
0.235
Share Price SpacerBid
0.22
Share Price SpacerAsk
0.25
Share Price SpacerChange
9.30%0.02
Share Price SpacerVolume
19,496,292
Share Price SpacerOpen
0.215
Share Price SpacerHigh
0.24
Share Price SpacerLow
0.215
Share Price SpacerClose
0.215
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 902.63m £2.12m 150,000

52 Week High 3.20 52 Week High Date 29-JUN-2018
52 Week Low 0.20 52 Week Low Date 13-JUN-2019

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
53 18,983,961 512,331 -0.250 -0.94 0.00 0.00


London South East Users info for Valirx




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

19-Jun-19
15:54:07
0.24
46,877
Buy* 
0.22
0.25
112.50
Trade Type:
Ordinary
NonProtected portfolio
Single protected transaction

19-Jun-19
15:51:21
0.2299
287,758
Sell* 
0.22
0.25
661.56
Trade Type:
Ordinary

19-Jun-19
15:33:31
0.2299
22,187
Sell* 
0.22
0.25
51.01
Trade Type:
Ordinary




View more Valirx trades >>

Directors Deals for Valirx (VAL)
Trade DateActionNotifierPriceCurrencyAmountHolding
18-Dec-18Placing
Trade Notifier Information for Valirx
Satu Vainikka held the position of CEO at Valirx at the time of this trade.
 Satu Vainikka
0.75GBX1,333,3331958242
18-Dec-18Placing
Trade Notifier Information for Valirx
George Morris held the position of Non-Executive Director at Valirx at the time of this trade.
 George Morris
0.75GBX1,333,3331821620
18-Dec-18Placing
Trade Notifier Information for Valirx
Alexander Oliver de Giorgio-Miller held the position of Non-Executive Chairman at Valirx at the time of this trade.
 Alexander Oliver de Giorgio-Miller
0.75GBX1,333,3331392888
View more Valirx directors dealings >>


Latino
Posts: 8,569
Opinion:No Opinion
Price:0.235
RE: Russell Cox on Twitter
Today 18:15
Take it with a pinch of salt these tweets, but it’s interesting.
Fredd1eboy
Posts: 5,068
Opinion:No Opinion
Price:0.235
Nick Slater
Today 17:22
The sites reporting 19m sold today and b'all bought....joke!!!!!... Anyway....27m bought or sold required to take NS through the 5% or 10% thresholds...So, at this rate, could be tomorrow....but I'm not holding my breath.
Trickymatters
Posts: 447
Opinion:No Opinion
Price:0.235
Russell Cox on Twitter
Today 16:35
Says that Citi are advising Roche who have just paid 2.6 billion for another little biotech in our field of cancer gene technology. They are rebuilding their portfolio. I was getting very close to selling but maybe I should buy some more now! This investment has not been easy. Hope is everlasting, Lol
Trickymatters
Posts: 447
Opinion:No Opinion
Price:0.235
Russell Cox on Twitter
Today 16:34
Says that Citi are advising Roche who have just paid 2.6 billion for another little biotech in our field of cancer gene technology. They are rebuilding their portfolio. I was getting very close to selling but maybe I should buy some more now! This investment has not been easy. Hope is everlasting, Lol
ValJu
Posts: 6,646
Opinion:No Opinion
Price:0.235
RE: I'm convinced......
Today 16:16
current 500k .231 to sell
View more share chat for Valirx (VAL) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk









Home  |  Contact Us  |  About Us  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy  |  Mobile Site  |  About this website design


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.